Physiomics Share Discussion Threads

[the stigologist] 22/7/2020 14:50

Brokers Hybridan : "MULTIPLE potential catalysts for share price appreciation"

[the stigologist] 22/7/2020 14:49

Great post Bones

[datait] 22/7/2020 14:48

Dont touch this for 2 weeks at least going under 10p again easy.

[datait] 22/7/2020 14:43

Buy on others fear

[datait] 22/7/2020 14:36

90% of the time.

GDR and ICON are the next ones to multy bag

[jusjusjus] 22/7/2020 14:36

can't trade again!

[datait] 22/7/2020 14:35

ohhhh I will be believe me been doing this over 25yrs know how the market makers work.

[montynj] 22/7/2020 14:35

Just added to my position at 10.9p...good level on chart here

[datait] 22/7/2020 14:34

Least you got 17p ohhhh you bought the 😝🤣🤣😆

[jusjusjus] 22/7/2020 14:34

somebody predicted red at end of day, we may have laughed, they may be laughing now!

[datait] 22/7/2020 14:33

Going red folks told you 🤣🤣🤣🤣

[computercoders] 22/7/2020 14:25

Double bottom on day chart

[computercoders] 22/7/2020 14:25

Double bottom on day chart

[bones] 22/7/2020 14:03

Anatomy of an RNS:

The Board of Physiomics plc (AIM: PYC), a provider of technology-based solutions to predict the effects of cancer treatment regimens for the biopharma industry, notes the recent rise in the Company's share price and trading volumes and advises the market that it knows of no specific reason for such significant movements (note 1).

Further to its announcements of 27 May 2020 and 30 June 2020, the Company remains in the late stages of finalising a contract with the potential new large pharmaceutical client (note 2). While there is no guarantee that the contract will be entered into (note 3), the commercial terms have been agreed (note 4) and the directors are confident it will be signed in the coming weeks (note 5). Should the contract be entered into, the project (note 6) would take two of our technical staff around five months to complete (note 7). Further updates will be provided as and when appropriate in due course.

Notes
1. No specific reason known. In other words, no unknown known, but as Stig said, plenty of general ones are known which are backing up a general re-rating in a very hot sector.
2. Reiteration of a pending deal with a large and new pharma client which simply reinforces the message and attracts new investors that missed it last time round. It can also offer the prospect that this deal might be the first of many with said large pharma which in turn attracts other peers over time if large players deal regularly with a “minnow”.
3. No guarantee that deal will be signed. They have to say this even if the chance of signing is 99.9%.
4. The commercial terms have been agreed. With respect to the opening of the RNS, this sounds like new news even if purportedly not “specific̶1; news.
5. In coming weeks allows a wide area of play. Could in practice be tomorrow, next week, two weeks....
6. Assuming the deal is agreed, what is the project? It could be in a blockbuster field of potential discovery. We just don’t know yet.
7. Two technical staff at five months each. We don’t know the salaries involved but that might typically represent a third of overall price charged? We do not know the value being attributed to the intellectual property being contributed here. It probably does not matter because it is all about gaining a reputation with large clients and demonstrating the value of the IP owned by Physiomics. It’s pointless guessing at the figures for this one project in isolation.

[flashheart] 22/7/2020 14:01

You can buy below the mid so will show as sells. 11.9p to buy as we speak.

[computercoders] 22/7/2020 14:01

Oh right sorry you're right I was looking st old trades just popped up from midday ffs

[jusjusjus] 22/7/2020 13:59

check the trade times, haven't seen a buy since 13:32!

[computercoders] 22/7/2020 13:55

Full ask getting hammered now with large buys. HOLD TIGHT!

[computercoders] 22/7/2020 13:55

Full ask just been paid peeps. I think it might go on a run again and retest 17p today or tomorrow. Once the market as digested today's news that terms agreed.